Renal protective effect of Rosa laevigata Michx. by the inhibition of oxidative stress in streptozotocin-induced diabetic rats

Molecular Medicine Reports

Volumn 5, Issue 6, 2012, Pages 1548-1554

  Zhou, Yujuan ^a,b   Liao, Qianjin ^b   Luo, Yuping ^b   Qing, Zhenqi ^b   Zhang, Qiuju ^b   He, Guoping ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

Diabetic nephropathy; Monocyte chemoattractant protein 1; Nuclear factor B; Oxidative stress; Rosa laevigata Michx

Indexed keywords

ALBUMIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MALONALDEHYDE; MONOCYTE CHEMOTACTIC PROTEIN 1; PLANT EXTRACT; REACTIVE OXYGEN METABOLITE; ROSA LAEVIGATA MICHX EXTRACT; STREPTOZOCIN; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CHINESE MEDICINE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; GLUCOSE BLOOD LEVEL; KIDNEY DYSFUNCTION; KIDNEY MASS; LIPID BLOOD LEVEL; MALE; MEDICINAL PLANT; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; ROSA LAEVIGATA MICHX; URINE VOLUME;

ANIMALS; CHEMOKINE CCL2; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; I-KAPPA B PROTEINS; KIDNEY; MALE; MALONDIALDEHYDE; MEDICINE, CHINESE TRADITIONAL; OXIDATIVE STRESS; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; ROSA; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR RELA;

RATTUS; ROSA LAEVIGATA;

EID: 84860703213     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.855     Document Type: Article

References (45)

1. Cooper ME: Is diabetic nephropathy disappearing from clinical practice? Pediatr Diabetes 7: 237-238, 2006.
2. Singh DK, Winocour P and Farrington K: Oxidative stress in early diabetic nephropathy: fueling the fire. Nat Rev Endocrinol 7: 176-184, 2011.
3. Kashihara N, Haruna Y, Kondeti VK and Kanwar YS: Oxidative stress in diabetic nephropathy. Curr Med Chem 17: 4256-4269, 2010.
4. Elmarakby AA and Sullivan JC: Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy. Cardiovasc Ther 30: 49-59, 2012.
5. Jones DP: Redefining oxidative stress. Antioxid Redox Signal 8: 1865-1879, 2006.
6. Goth L: Reactive oxygen species, hydrogen peroxide, catalase and diabetes mellitus. Redox Rep 11: 281-282, 2006.
7. Fatehi-Hassanabad Z, Chan CB and Furman BL: Reactive oxygen species and endothelial function in diabetes. Eur J Pharmacol 636: 8-17, 2010.
8. Kaneto H, Katakami N, Matsuhisa M and Matsuoka TA: Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis. Mediators Inflamm 2010: 453892, 2010.
9. Scandalios JG: Oxidative stress: molecular perception and transduction of signals triggering antioxidant gene defenses. Braz J Med Biol Res 38: 995-1014, 2005.
10. Liu WH, Hei ZQ, Nie H, et al: Berberine ameliorates renal injury in streptozotocin-induced diabetic rats by suppression of both oxidative stress and aldose reductase. Chin Med J 121: 706-712, 2008.
11. Firenzuoli F and Gori L: Herbal medicine today: clinical and research issues. Evid Based Complement Alternat Med 4 (Suppl 1): 37-40, 2007.
12. Rong J, Cheung CY, Lau AS, Shen J, Tam PK and Cheng YC: Induction of heme oxygenase-1 by traditional Chinese medicine formulation ISF-1 and its ingredients as a cytoprotective mechanism against oxidative stress. Int J Mol Med 21: 405-411, 2008. (Pubitemid 351802634)
13. Xu GJ, He HX, Xu LS and Jin RY: Chinese Materia Medical. Chinese Medicinal Science & Technology Publishing House: Beijing 7: 223, 1998.
14. Health. SPCotMoP: Pharmacopoeia of the People's Republic of China 2005. Chemical Industry Press, Beijing, P.R. China 1: 1, 2005.
15. Choi SJ, Kim MJ, Heo HJ, et al: Protective effect of Rosa laevigata against amyloid beta peptide-induced oxidative stress. Amyloid 13: 6-12, 2006.
16. Zhang QJ, Yin WD, Xi SM, et al: Effects of Fructus Rosa Laevigata and membrance of chickens gizzard on serum glucose, lipid and insulin levels in rabbits. Chin J Arterioscler 11: 227-229, 2003.
17. Zhou YJ, Liao QJ, Zhang QJ, Qin ZQ, Tang HL and Song Y: Experimental study of Rosa Laevigata Mickx in streptozotocin-induced diabetic rats. J Nanhua Univ (Medical Edition) 35: 332-335, 2007.
18. Zhou YJ, Liao QJ, Zhang QJ and Qin Z: Effect of Rosa Laevigata on expression of MCP-1 in rats with diabetic nephropathy. Prog Mod Biomed 9: 4425-4427, 2009.
19. Levin-Iaina N, Iaina A and Raz I: The emerging role of NO and IGF-1 in early renal hypertrophy in STZ-induced diabetic rats. Diabetes Metab Res Rev 27: 235-243, 2011.
20. Ni T, Hu Y, Sun L, et al: Oral route of mini-proinsulin-expressing Ganoderma lucidum decreases blood glucose level in streptozocin-induced diabetic rats. Int J Mol Med 20: 45-51, 2007.
21. Bhaskaran N, Shukla S, Srivastava JK and Gupta S: Chamomile: an anti-inflammatory agent inhibits inducible nitric oxide synthase expression by blocking RelA/p65 activity. Int J Mol Med 26: 935-940, 2011.
22. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)). Methods 25: 402-408, 2001. (Pubitemid 34164012)
23. Jacob A, Rajan D, Pathickal B, et al: The inhibitory effect of ghrelin on sepsis-induced inflammation is mediated by the MAPK phosphatase-1. Int J Mol Med 25: 159-164, 2010.
24. Andersen AR, Christiansen JS, Andersen JK, Kreiner S and Deckert T: Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 25: 496-501, 1983. (Pubitemid 14200886)
25. Scivittaro V, Ganz MB and Weiss MF: AGEs induce oxidative stress and activate protein kinase C-beta(II) in neonatal mesangial cells. Am J Physiol Renal Physiol 278: F676-F683, 2000. (Pubitemid 30215247)
26. Danda RS, Habiba NM, Rincon-Choles H, et al: Kidney involvement in a nongenetic rat model of type 2 diabetes. Kidney Int 68: 2562-2571, 2005. (Pubitemid 43251001)
27. Noh H and Ha H: Reactive oxygen species and oxidative stress. Contrib Nephrol 170: 102-112, 2011.
28. Giacco F and Brownlee M: Oxidative stress and diabetic complications. Circ Res 107: 1058-1070, 2010.
29. Ha H and Lee HB: Reactive oxygen species as glucose signaling molecules in mesangial cells cultured under high glucose. Kidney Int 77: S19-S25, 2000.
30. Iglesias-De La Cruz MC, Ruiz-Torres P, Alcami J, et al: Hydrogen peroxide increases extracellular matrix mRNA through TGF-beta in human mesangial cells. Kidney Int 59: 87-95, 2001. (Pubitemid 32055217)
31. Fridovich I: Superoxide radical and superoxide dismutases. Annu Rev Biochem 64: 97-112, 1995.
32. DeRubertis FR, Craven PA, Melhem MF and Salah EM: Attenuation of renal injury in db/db mice overexpressing superoxide dismutase: evidence for reduced superoxide-nitric oxide interaction. Diabetes 53: 762-768, 2004. (Pubitemid 38270647)
33. Peixoto EB, Pessoa BS, Biswas SK and Lopes de Faria JB: Antioxidant SOD mimetic prevents NADPH oxidase-induced oxidative stress and renal damage in the early stage of experimental diabetes and hypertension. Am J Nephrol 29: 309-318, 2009.
34. Fujita H, Fujishima H, Chida S, et al: Reduction of renal superoxide dismutase in progressive diabetic nephropathy. J Am Soc Nephrol 20: 1303-1313, 2009.
35. Hermanns RC, de Zwart LL, Salemink PJ, Commandeur JN, Vermeulen NP and Meerman JH: Urinary excretion of biomarkers of oxidative kidney damage induced by ferric nitrilotriacetate. Toxicol Sci 43: 241-249, 1998. (Pubitemid 28363397)
36. Chang JM, Kuo MC, Kuo HT, Chiu YW and Chen HC: Increased glomerular and extracellular malondialdehyde levels in patients and rats with diabetic nephropathy. J Lab Clin Med 146: 210-215, 2005.
37. Calcutt NA, Cooper ME, Kern TS and Schmidt AM: Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials. Nat Rev Drug Discov 8: 417-429, 2009.
38. Kern TS: Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp Diabetes Res 2007: 95103, 2007.
39. Yozai K, Shikata K, Sasaki M, et al: Methotrexate prevents renal injury in experimental diabetic rats via anti-inflammatory actions. J Am Soc Nephrol 16: 3326-3338, 2005. (Pubitemid 46179336)
40. Tesch GH: MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy. Am J Physiol Renal Physiol 294: F697-F701, 2008.
41. Gruden G, Setti G, Hayward A, et al: Mechanical stretch induces monocyte chemoattractant activity via an NF-kappaB-dependent monocyte chemoattractant protein-1-mediated pathway in human mesangial cells: inhibition by rosiglitazone. J Am Soc Nephrol 16: 688-696, 2005. (Pubitemid 41725105)
42. Chow FY, Nikolic-Paterson DJ, Ma FY, Ozols E, Rollins BJ and Tesch GH: Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice. Diabetologia 50: 471-480, 2007.
43. Kanamori H, Matsubara T, Mima A, et al: Inhibition of MCP-1/CCR2 pathway ameliorates the development of diabetic nephropathy. Biochem Biophys Res Commun 360: 772-777, 2007. (Pubitemid 47077388)
44. Ha H, Yu MR, Choi YJ, Kitamura M and Lee HB: Role of high glucose-induced nuclear factor-kappaB activation in monocyte chemoattractant protein-1 expression by mesangial cells. J Am Soc Nephrol 13: 894-902, 2002. (Pubitemid 34274085)
45. Hwang SY, Woo CW, Au-Yeung KK, Siow YL, Zhu TY and O K: Homocysteine stimulates monocyte chemoattractant protein-1 expression in the kidney via nuclear factor-kappaB activation. Am J Physiol Renal Physiol 294: F236-F244, 2008.